Hepatitis

  • 3rd among reported diseases in incidence (STDs and chicken pox – #1 & #2)
  • 1-2 million deaths worldwide
  • 1.2 million Hep B carriers in the U.S.
  • 300 million carriers worldwide

Acute Hepatitis

Asymptomatic Hepatitis

  • inapparent disease unless the patient somehow gets liver function tests
  • HAV is especially at risk for being asymptomatic

Symptomatic Hepatitis

  • Icteric
  • Anicteric – insufficient elevation of bilirubin to produce jaundice. Hard diagnosis
  • Extrahepatic manifestations – HBV and HCV – due to circulating Ag-Ab complexes rash, arthritis, vasculitis, glomerulonephritis

Relative Frequency of Acute Hepatitis

Sporadic Cases

  • HAV> HCV> HBV> rest
  • Difficult to assess because HCV and HAV may be unrecognized blood transfusion related cases

INCUBATION PERIODS

HAV                 15-60  days

HEV                  15-64  days

HBV                 45-160 days

HDV                45-180 days

HCV                14-180 days

HGV                unknown

Epidemiology and Transmission

HAV

  • ssRNA
  • Human is only reservoir
  • Fecal-Oral Transmission
  • Lower socio-economic class gets it more
  • In 3rd world countries most cases are asymptomatic and in children
  • NO CARRIER STATE, NO CHRONIC DISEASE

HBV

  • ONLY ONE THAT IS DNA VIRUS
  • Human is principal reservoir
  • Parental, perinatal, and venereal transmission
  • Increasing in incidence in U.S.
  • HbsAg – 5-10% of U.S. population
  • Anti-HBs = immune
  • Anti-HBc = not immune
  • HbeAg = active replication in serum
  • Incidence very high in Asia, Pacific Islands, Africa, and Middle East (75-90% of population)
  • Pathognomonic – ground glass cell (pink eosinophilic)
  • Pathophysiology – CD8 cells trying to destroy the virus cause hepatocyte damage also.
  • Risk factor for hepatocellular CA

HDV

  • PATIENT MUST HAVE HBV; SYMBIOTIC WITH HBV
  • Superinfections have worse prognosis than when coinfected at the same time.
  • Usu. IV drug use or sexual contact
  • Up to 70% of patients develop cirrhosis

HCV

  • ssRNA
  • 1-2% carrier rate in U.S.
  • ONLY ONE THAT HAS BILE DUCT INFLAMATION
  • 80-95% or majorityof patients get chronic liver disease
  • Even more of a risk factor for Hepatocellular CA than HBV

HEV

  • clinically similar to HAV, no relation
  • fecal-oral
  • high mortality rate among pregnant women
  • no chronic disease reported

HGV

  • new RNA virus
  • some of the cases of transfusio related hepatitis
  • does have a dhronic state and can also be present with HCV or HBV

Non A-E viruses

  • goes to the other cases of transfusion and sporadic related hepatitis

Clinical Manifestations

  • Non-specific and flu-like
  • Lassitude, loss of appetite, nausea, weakness, fever, vomiting, headache, chills, abdominal discomfort, myalgia, drowsiness.

Morphology of Acute Viral Hepatitis

  • entire liver is involved
  • histologic picture is the sum of hepatocyte necrosis, hepatocyte regeneration, inflammation and repair.

Classic Pattern

  • patchy necrosis in lobule (more in zone 3 than in zone 1)
  • Lobular architectural disarray
  • Predominance of lymphocytes
  • Hyperplasia and hypertrophy of Kupffer Cells
  • Cholestasis may or may not be present

Bridging (Submassive) Necrosis

  • necrosis bridging between portal tracts and central veins
  • young patients – bridging necrosis has no effect on prognosis
  • older patients – bad prognosis and many will eventually go on the cirrhosis or die acutely

Massive Necrosis

  • multilobular necrosis with few or no surviving hepatocytes
  • liver small, soft and very flexible
  • only the fibrous and reticulin structure of the liver is left
  • poor survival rate
  • if patients survive, liver regenerates back to normal without cirrhosis.

Sequelae of Acute Hepatitis Infection

HAV                 HAB                 HCV

Complete Recovery                              99%                 80-85%             0-20%

Fulminant Hepatitis                               rare                  yes                   yes

Carrier State                                         no                    yes                   yes

Chronic Hepatitis                                  no                    5-10%              80-100%

Cirrhosis                                              no                    10-30%             20%

Hepatocellular CA                                 no                    yes                   yes

Chronic Hepatitis

  • evidence of continuing or relapsing hepatic disease for at least 6 mths.
  • May be benign or progress to cirrhosis

Etiology of Chronic Hepatitis

  • HCV, HBV, HDV, HGV, No-A-E viruses
  • Autoimmune diseases
  • Drug related ( Ex. Isoniazid )

Chronic Hepatitis – Clinical

  • Common: fatigue, lethargy, increased need for sleep, lack of energy
  • Less Common: poor appetite, intermittent nausea, pain over liver, muscle aches, mental depression
  • CORRELATION IS POOR SYMPTOMS AND SEVERITY OF DISEASE

Chronic Hepatitis – Types

  • Chronic persistent hepatitis
  • Chronic Active Hepatitis
  • Chronic Lobular Hepatitis
  • Other liver disease other than chronic hepatitis that can cause piecemeal necrosis

Ø  Primary biliary cirrhosis, primary sclerosing cholangitis, Wilson’s disease, Alpha-1-antitrypsin disease, Alcoholic liver disease.

Acute Alcoholic Liver Disease

Fatty Metamorphosis

  • universal, immediate, reversible
  • metabolism of EtOH is culprit
  • mild to none – clinical complications
  • no cirrhosis
  • Benign except for “sudden death syndrome”

Acute Alcoholic Hepatitis

  • not very well understood
  • can be reversed if early; patient must stop alcohol intake
  • can lead to cirrhosis
  • manifestations vary greatly – asymptomatic to jaundiced to critically ill
  • Most common physical finding – hepatomegaly (ascites, jaundice, splenomegaly, and encephalopathy also found
  • NOT benign
  • Only prevention – stop alcohol intake
  • Morphological changes

Ø  Mallory’s Hyaline is Hallmark

Ø  Neutrophilic inflammatory infiltrate

Ø  Must have these two

  • other entities assoc. with centrilobular Mallory’s hyaline: jejunoileal bypass, drugs, non-alcoholic steatohepatitis, rarely obesity, rarely diabetes mellitus
  • other entities assoc. with peripheral lobular Mallory’s hyaline: cholestasis, 1o biliary cirrhosis, 1o sclerosing cholangitis, indian childhood cirrhosis, Wilson’s disease, pulmonary asbestosis, cryptogenic cirrhosis

Tags: , , , , , , , , , , , , , , , ,